Protocol of a prospective study on the diagnostic value of transcranial duplex scanning of the substantia nigra in patients with parkinsonian symptoms
- PMID: 17784944
- PMCID: PMC2034584
- DOI: 10.1186/1471-2377-7-28
Protocol of a prospective study on the diagnostic value of transcranial duplex scanning of the substantia nigra in patients with parkinsonian symptoms
Abstract
Background: Parkinson's disease (PD) is the second most common neurodegenerative disorder. As there is no definitive diagnostic test, its diagnosis is based on clinical criteria. Recently transcranial duplex scanning (TCD) of the substantia nigra in the brainstem has been proposed as an instrument to diagnose PD. We and others have found that TCD scanning of substantia nigra duplex is a relatively accurate diagnostic instrument in patients with parkinsonian symptoms. However, all studies on TCD so far have involved well-defined, later-stage PD patients, which will obviously lead to an overestimate of the diagnostic accuracy of TCD. We have therefore set out to conduct a prospective study testing the diagnostic accuracy of TCD in patients with a parkinsonism of unclear origin.
Methods/design: We will enroll 250 consecutive patients, who are referred to neurology outpatient clinics of two teaching hospitals, for analysis of clinically unclear parkinsonism. Patients, whose parkinsonism is clearly diagnosable at the first visit, will be excluded from the study. All patients will undergo a TCD of the substantia nigra. As a surrogate gold standard we will use the consensus clinical diagnosis reached by two independent, blinded, movement disorder specialist neurologists after 2 years follow-up. At the time of TCD, patients will also undergo a SPECT scan of the brain.
Discussion: As this prospective trial enroll only patients with an early-stage parkinsonism, it will yield data on the diagnostic accuracy of TCD that is relevant to daily clinical practice: The neurologist needs a diagnostic tool that provides additional information in patients with a clinically indefinable parkinsonian syndrome. The above described observational longitudinal study was designed to explicitly study this aspect in the diagnostic process.
Trial registration: ClinicalTrials.gov NCT00368199.
Similar articles
-
The predictive value of transcranial duplex sonography for the clinical diagnosis in undiagnosed parkinsonian syndromes: comparison with SPECT scans.BMC Neurol. 2008 Nov 9;8:42. doi: 10.1186/1471-2377-8-42. BMC Neurol. 2008. PMID: 18992168 Free PMC article.
-
Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study.Eur J Neurol. 2019 Nov;26(11):1370-1376. doi: 10.1111/ene.13988. Epub 2019 Jun 27. Eur J Neurol. 2019. PMID: 31094036
-
Transcranial sonography and (123)I-FP-CIT single photon emission computed tomography in movement disorders.Ultrasound Med Biol. 2014 Oct;40(10):2365-71. doi: 10.1016/j.ultrasmedbio.2014.05.014. Ultrasound Med Biol. 2014. PMID: 25194454
-
Substantia nigra hyperechogenicity in Parkinson's disease.Acta Neurochir (Wien). 2010 Dec;152(12):2085-7. doi: 10.1007/s00701-010-0736-0. Epub 2010 Jul 11. Acta Neurochir (Wien). 2010. PMID: 20623147 Review. No abstract available.
-
Accuracy of Transcranial Sonography of the Substantia Nigra for Detection of Parkinson's Disease: A Systematic Review and Meta-analysis.Ultrasound Med Biol. 2019 Mar;45(3):628-641. doi: 10.1016/j.ultrasmedbio.2018.11.010. Epub 2019 Jan 3. Ultrasound Med Biol. 2019. PMID: 30612821
Cited by
-
Specificity and sensitivity of transcranial sonography of the substantia nigra in the diagnosis of Parkinson's disease: prospective cohort study in 196 patients.BMJ Open. 2013 Apr 2;3(4):e002613. doi: 10.1136/bmjopen-2013-002613. Print 2013. BMJ Open. 2013. PMID: 23550093 Free PMC article.
-
Abnormal Echogenicity of the Substantia Nigra, Raphe Nuclei, and Third-Ventricle Width as Markers of Cognitive Impairment in Parkinsonian Disorders: A Cross-Sectional Study.Parkinsons Dis. 2016;2016:4058580. doi: 10.1155/2016/4058580. Epub 2016 Jan 10. Parkinsons Dis. 2016. PMID: 26881179 Free PMC article.
-
Utility of Combining Transcranial Sonography and MIBG Myocardial Scintigraphy to Evaluate Substantia Nigra in Patients with Parkinson's Disease.Brain Sci. 2024 May 21;14(6):524. doi: 10.3390/brainsci14060524. Brain Sci. 2024. PMID: 38928525 Free PMC article.
-
Transcranial sonography findings related to depression in parkinsonian disorders: cross-sectional study in 126 patients.PeerJ. 2016 May 18;4:e2037. doi: 10.7717/peerj.2037. eCollection 2016. PeerJ. 2016. PMID: 27231659 Free PMC article.
-
Neurologists' diagnostic accuracy of depression and cognitive problems in patients with parkinsonism.BMC Neurol. 2012 Jun 15;12:37. doi: 10.1186/1471-2377-12-37. BMC Neurol. 2012. PMID: 22702891 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials